Results 141 to 150 of about 183,209 (216)

Histon-Deacetylase [PDF]

, 2018
openaire   +1 more source

NF-κB Is a Potential Therapeutic Target for Histone Deacetylase Inhibitor-Resistant Cutaneous T-Cell Lymphoma. [PDF]

Cancer Sci
Takahashi Y, Kitadate A, Iwama S, Kuroki W, Abe K, Yamada M, Ikeda S, Tagawa H, Wakui H, Hikida M, Takahashi N.   +10 more
europepmc   +1 more source

Recent Insights into the Creation of Histone Deacetylase Inhibitors for the Treatment of Human Diseases. [PDF]

Int J Mol Sci
Yudaev P, Aleksandrova Y, Neganova M.
europepmc   +1 more source

Phosphatidylinositol-3-Kinase (PI3K) and Histone Deacetylase (HDAC) Multitarget Inhibitors: An Update on Clinical and Preclinical Candidates. [PDF]

Pharmaceuticals (Basel)
Lima ADS, Lima LM.
europepmc   +1 more source

Histone deacetylase

Drug Delivery System, 2003
openaire   +1 more source

Role of Histone Deacetylase and Inhibitors in Cardiovascular Diseases. [PDF]

Cell Prolif
Zhang LY, Wang YY, Wen R, Zhang TN, Yang N.   +4 more
europepmc   +1 more source

Histone deacetylase 7 mediates lipopolysaccharide-inducible mitochondrial fission in macrophages. [PDF]

J Cell Sci
Abrol R, Afroz SF, Curson JEB, Raven KD, Das Gupta K, Gunther KS, Jones A, Reid RC, Xiong Z, Gunter JH, Engel JA, Engwerda CR, Blumenthal A, Fairlie DP, Parton RG, Zuryn S, Kapetanovic R, Ramnath D, Sweet MJ.   +18 more
europepmc   +1 more source

Histone deacetylase 6 (HDAC6); histone deacetylase 8 (HDAC8) [PDF]

Science-Business eXchange, 2013
openaire   +1 more source

Histone deacetylase 4: A therapeutic target for cardiovascular diseases (Review). [PDF]

Int J Mol Med
Ma X, Wei R, Song A, Zhang X, Zou J, Hao S.   +5 more
europepmc   +1 more source

Thermal shift engagement assay for Class IIA histone deacetylase inhibitor screening. [PDF]

Results Chem
Kotsull LN, Pflum MKH.
europepmc   +1 more source